HC Wainwright & Co. Initiates Coverage On Electra Therapeutics with Buy Rating, Announces Price Target of $30
Benzinga Newsdesk 4 days ago
Analyst RatingsNewsInitiationPrice Target
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Buy rating and announces Price Target of $30.
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Buy rating and announces Price Target of $30.